July 21 Webinar: Unpacking the Latest Prostate Cancer Discoveries

Join us for an informal discussion of critical prostate cancer updates, and how they may impact your care.

Register Now

PCF Webinar Series with Dr. Koo and Dr. Klaassen

New FDA Approval for Darolutamide

Patients with metastatic hormone-sensitive prostate cancer have an additional treatment option.

Learn More

Patient Talking to Doctor- Expanded FDA Approval Means More Treatment Options

Tackling Prostate Cancer’s Toughest Challenges

PCF holds the Coffey-Holden Prostate Cancer Academy, an invitation-only “think tank” where about 75 top scientists share their prostate cancer research and brainstorm new solutions to critical problems facing patients today.

Learn More

Group of scientists smile for the camera in front of a building

The Prostate Cancer Foundation has worked since 1993 to end death and suffering from prostate cancer through research, providing effective treatments for patients and families.

About PCF  

Ways to Take Action

Our Work

Patient Support

The Latest

George Zhao, MD

“The Prostate Cancer Foundation Young Investigator Award was crucial in jumpstarting my career. It not only funded important research but also helped me secure a physician-scientist position.”

The Work We Fund

Benny Johnson, Jr.

“Meeting Dr. King made it a little more lighter. When I met her, she told me some things we can do because in between that, my sexual situation was up and down, and more down than up at that particular point. So we figured we had to do something about that.”

Sexual Health